BLRX
BioLineRX
BLRX
BLRX
28 hedge funds and large institutions have $33.1M invested in BioLineRX in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less capital invested
Capital invested by funds: $40.9M → $33.1M (-$7.85M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$684K | |
| 2 | +$72K | |
| 3 | +$61K | |
| 4 |
MCC
Malaga Cove Capital
Pv Estates,
California
|
+$43K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$30K |
Top Sellers
| 1 | -$183K | |
| 2 | -$157K | |
| 3 | -$95K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$48K |
| 5 |
JPMorgan Chase & Co
New York
|
-$31K |